BIO.WA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:00):

Stats
Today's Volume	48 068.00
Average Volume	25 296.00
Market Cap	300.52M
EPS	PLN-0.0514 ( 2023-09-30 )
Last Dividend	PLN0 ( N/A )
Next Dividend	PLN0 ( N/A )
P/E	116.67
ATR14	PLN0.00100 (0.03%)

Volume Correlation

Long: 0.15 (neutral)

Short: 0.53 (weak)

Signal:(34.947) Neutral

BIOTON S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BIOTON S.A. Correlation - Currency/Commodity

-0.04
( neutral )

0.05
( neutral )

0.00
( neutral )

0.27
( neutral )

BIOTON S.A. Financials

Annual	2023
Revenue:	PLN181.64M
Gross Profit:	PLN72.85M (40.11 %)
EPS:	PLN0.0265

Q4	2023
Revenue:	PLN47.52M
Gross Profit:	PLN19.87M (41.80 %)
EPS:	PLN0.0629

Q3	2023
Revenue:	PLN50.70M
Gross Profit:	PLN14.48M (28.56 %)
EPS:	PLN-0.0514

Q2	2023
Revenue:	PLN49.04M
Gross Profit:	PLN18.84M (38.42 %)
EPS:	PLN0.0166

Financial Reports:

No articles found.

BIOTON S.A.

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.